Physician profile
David Qiang Wan
NPI 1376599555
$2,286.03
in general payments reported to CMS, 2019-2025
7 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Nuclear Radiology provider received nationally (typical 2025 total: $145).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.77 · 2020: $120 · 2021: $94.94 · 2022: $70.11 · 2023: $1,398 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,034 · Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,034.15 |
| Food and Beverage | $870.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,430.79 | 2022-2023 | |
| Astellas Pharma US INC | $311.59 | 2019-2021 | |
| United Imaging Healthcare North America, INC. | $285.00 | 2025 | N/A |
| Viiv Healthcare Company | $123.65 | 2025 | Cabenuva |
| Janssen Biotech, INC. | $97.28 | 2025 | Tremfya |
| Telix Pharmaceuticals | $19.38 | 2023 | Illuccix |
| Blue Earth Diagnostics | $18.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.